Extranodal NK/T Cell Lymphoma Clinical Trial
Official title:
Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma
NCT number | NCT01341119 |
Other study ID # | 2010-11-047 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | April 21, 2011 |
Last updated | August 6, 2012 |
Start date | November 2010 |
Verified date | August 2012 |
Source | Samsung Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | South Korea: Institutional Review Board |
Study type | Observational |
To study clinical features, prognostic factors and treatment outcome and to develop a possible prognostic index in skin/soft tissue primary NK/T cell lymphoma patients.
Status | Completed |
Enrollment | 40 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - histologically confirmed extranodal NK/T cell lymphoma - primary site is skin or soft tissue Exclusion Criteria: - involvement of upper aerodigestive tract |
Observational Model: Cohort, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Samsung Medical Center | Seoul |
Lead Sponsor | Collaborator |
---|---|
Samsung Medical Center |
Korea, Republic of,
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05426824 -
The Whole-course Management of Pegaspargase in ENKTL
|
N/A |